Top Section/Ad
Top Section/Ad
Most recent
BWICs spike and spreads widen but market remains constructive
Resets and refis prominent in pipeline as loan market softens, offering respite from repricing wave
Dasha Sobornova joins from Akin Gump with experience across asset classes
Trade body for levfin investors turns to leading rating analyst
More articles/Ad
More articles/Ad
More articles
-
GlobalCapital held its annual European CLO awards on April 4 in London, presenting this year’s winners at the IMN Investors’ Conference on European CLOs and Leveraged Loans. -
Upbeat headlines and a subsequent jump in the stock price of Valeant Pharmaceuticals has lifted the mood of US CLO investors, who had believed that troubles at the Canadian drug company would drive defaults in exposed CLOs.
-
The wide range in pricing of new issue CLO paper is being driven by differing views of the market between US and Japanese buyers, according to market participants.
-
Next year’s deadline for Volcker Rule compliance for securities issued before 2013 is likely to further exacerbate the liquidity crunch in the CLO market, sources told GlobalCapital.
-
Continued pressure on equity investors means the European CLO market could be facing a muted second quarter, despite a recent flurry of deals in March, according to panellists at IMN’s Investors’ Conference on European CLOs and Leveraged Loans, held in London on Monday.
-
Goldman Sachs has sold a $451.1 CLO for Canyon Advisors, closing out an otherwise quiet week for the primary CLO market.
